Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin-Reference-Cited by-同舟云学术

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

Published:2022-05-18 Issue:5 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Pillay Samantha¹,Steingart Karen R²,Davies Geraint R³,Chaplin Marty⁴,De Vos Margaretha⁵,Schumacher Samuel G⁵,Warren Rob¹,Theron Grant¹

Affiliation:

1. DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences; Stellenbosch University; Cape Town South Africa

2. Honorary Research Fellow; Department of Clinical Sciences, Liverpool School of Tropical Medicine; Liverpool UK

3. Institute of Infection, Veterinary and Ecological Sciences; University of Liverpool; Liverpool UK

4. Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK

5. FIND; Geneva Switzerland

Publisher

Wiley

Subject

Pharmacology (medical)

Reference106 articles.

1. Omar S Shining a new light on TB diagnostics: clinical evaluation of the Xpert® MTB/XDR assay 51st Union World Conference on Lung Health, virtual conference

2. Omar S Shining a new light on TB diagnostics: clinical evaluation of the Xpert® MTB/XDR assay 51st Union World Conference on Lung Health, virtual conference

3. Omar S Ismail N Shining a new light on TB diagnostics: clinical evaluation of the Xpert® MTB/XDR assay 51st Union World Conference on Lung Health, virtual conference

4. Penn-Nicholson A Georghiou SB Ciobanu N Kazi M Bhalla M David A Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study Lancet Infectious Diseases 2021 Oct 7 [Epub ahead of print] 10.1016/S1473-3099(21)00452-7

5. Penn-Nicholson A Georghiou SB Ciobanu N Kazi M Bhalla M David A Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study Lancet Infectious Diseases 2021 Oct 7 [Epub ahead of print] 10.1016/S1473-3099(21)00452-7

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct Detection of Fluoroquinolone Resistance in Sputum Samples from Tuberculosis Patients by High Resolution Melt Curve Analysis;Current Microbiology;2023-12-02

2. To Test or Not? Xpert MTB/RIF as an Alternative to Smear Microscopy to Guide Line Probe Assay Testing for Drug-Resistant Tuberculosis;Journal of Clinical Microbiology;2023-07-20

3. Rolling out new anti-tuberculosis drugs without diagnostic capacity;Breathe;2023-06

4. Metabolomic analysis of Mycobacterium tuberculosis reveals metabolic profiles for identification of drug-resistant tuberculosis;Scientific Reports;2023-05-27

5. Evaluation of Xpert^®MTB/XDR test for susceptibility testing ofMycobacterium tuberculosisto first and second-line drugs in Uganda;2023-04-05